Ph IIa, randomized, double blind placebo controlled trial of EIDD-2801 to eliminate COVID Viral RNA detection
Clinical Trial Grant
Administered By
Medicine, Infectious Diseases
Awarded By
Ridgeback Biotherapeutics LP
Start Date
October 6, 2020
End Date
June 28, 2022
Administered By
Medicine, Infectious Diseases
Awarded By
Ridgeback Biotherapeutics LP
Start Date
October 6, 2020
End Date
June 28, 2022